Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Philip Morris' premium valuations are justified by ZYN's FDA approval, smoke-free growth, and market dominance. See why PM ...
Ambea has entered into an agreement to acquire Validia Oy, a leading care provider in Finland, from Invalidilitto, the Finnish Association of People with Physical Disabilities. This positions Ambea fo ...